ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Polyganics Initiates First-in-Human Trial of LIQOSEAL?, its Innovative Approach for Dural Closure
b3cnewswire
November 10, 2018The trial, titled ‘ENCASE’, is a single-arm, open-label study, evaluating safety and performance of LIQOSEAL? in reducing CSF leakage following elective cranial surgery. Up to 40 adult patients will be recruited at three sites across the Netherlands and S
Pharma Sources Insight January 2025
